Significant funding for neglected disease R&D Is Driving The Neglected Tropical Disease Diagnosis Market
The
global neglected tropical diseases diagnosis market size
is expected to reach USD 7.6 billion by 2025, according to a new report by
Grand View Research, Inc., exhibiting a 4.1% CAGR during the forecast period.
The combined effect of high impact factors such as soaring disease burden,
growing demand for early disease identification, and complementary advancements
in technology is expected to drive growth in demand.
Rising
concern regarding Neglected Tropical Diseases (NTD) and its global impact on
population as well as governments has fueled demand for development of early
disease detection methods. This growth in concern is evident by launch of a
substantial number of programs aiming to combat NTDs.
For
instance, the Global Network for Neglected Tropical Diseases aims to raise
awareness and funding, both of which are essential to control and eliminate the
most common NTDs. In addition, various companies are undertaking efforts to
develop less complicated and inexpensive diagnostic assays for tropical
diseases. This, in turn, is anticipated to support the growth of this market
throughout the forecast period.
Browse full
research report on Neglected Tropical Disease Diagnosis Market: www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market
Further
key findings from the report suggest:
- By disease type, dengue captured the largest
share over other NTDs in 2016. Growing dengue cases and development of
novel products for its diagnosis is expected to help this segment maintain
its dominance in the coming years
- Conventional diagnostic methods accounted for
the majority share owing to high market penetration of these techniques,
including pathogen culturing, biochemical methods, gram staining, and
serology tests
- Molecular/modern diagnostic methods are growing
at a lucrative pace and are expected to supplant conventional techniques
in the coming years. This is majorly due to the advantages of molecular
tests with respect to accuracy, specificity, and timelines
- Centralized services held the largest share in
2016 owing to easy access to these services; however, point-of-care
testing (POCT) services are anticipated exhibit lucrative growth in the
coming years owing to benefits such as portability and ease of use
- By end use, home healthcare is expected to be
the fastest growing segment as a result of growing popularity and demand
for POCT services
- Asia Pacific is estimated to be the largest
regional market and is expected to maintain its position throughout the forecast
period thanks to constant growth in GDP, presence of a large target
population, and high prevalence of neglected tropical diseases in the
region
- Abbott; F. Hoffmann-La Roche Ltd.; Thermo
Fisher Scientific, Inc.; and Omega Diagnostics Group PLC are some of the
key players operating in this market.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global neglected tropical diseases
diagnosis market on the basis of disease, diagnostic method, end use, service
type, and region:
Neglected
Tropical Diseases Diagnosis Disease Outlook (Revenue, USD Million, 2014 - 2025)
- Dengue
- Chikungunya
- Rabies
- Leprosy
- Buruli
Ulcer
- Yaws
- Lymphatic
Filariasis
- Taeniasis/Cysticercosis
- Foodborne
Trematodiases
- Echinococcosis
- Chagas
Disease (American Trypanosomiasis)
- Dracunculiasis
- African
Trypanosomiasis
- Soil-transmitted
Helminth Infections
- Onchocerciasis
- Schistosomiasis
- Scabies
and Other Ectoparasites
- Snakebite
Envenoming
- Leishmaniasis
Neglected
Tropical Diseases Diagnosis Diagnostic Method Outlook (Revenue, USD Million,
2014 - 2025)
- Conventional
Method
- Molecular/Modern
Method
Neglected
Tropical Diseases Diagnosis Service Type Outlook (Revenue, USD Million, 2014 -
2025)
- Centralized
Service
- POC
Service
Neglected
Tropical Diseases Diagnosis End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Clinical
Labs
- Hospitals
/Clinics
- Home
Healthcare
Neglected
Tropical Diseases Diagnosis Regional Outlook (Revenue, USD Million, 2014 -
2025)
- Asia
Pacific
- India
- China
- Indonesia
- Malaysia
- Latin
America
- Brazil
- Venezuela
- Colombia
- Middle
East & Africa
- Nigeria
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-neglected-tropical-diseases-diagnosis-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment